Stockreport

BeOne Medicines (ONC) Gains Barclays Overweight Rating Ahead of Key 2025 Data Readouts [Yahoo! Finance]

BeOne Medicines Ltd. - American Depositary Shares  (ONC) 
PDF of BeOne Medicines Ltd. (NASDAQ:ONC), rating it Overweight and setting a price target of $385 on the company's shares. The firm cited two anticipated “value-inflecting p [Read more]